If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Rosalba Miceli is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 4 Similar Profiles
Survival Medicine & Life Sciences
Sarcoma Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Recurrence Medicine & Life Sciences
Nomograms Medicine & Life Sciences
Breast Neoplasms Medicine & Life Sciences
Disease-Free Survival Medicine & Life Sciences
Neoplasm Metastasis Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1995 2019

  • 8541 Citations
  • 47 h-Index
  • 192 Article
  • 2 Comment/debate
  • 2 Review article
  • 1 Letter

Dose-adjusted EPOCH plus rituximab improves the clinical outcome of young patients affected by double expressor diffuse large B-cell lymphoma

Dodero, A., Guidetti, A., Tucci, A., Barretta, F., Novo, M., Devizzi, L., Re, A., Passi, A., Pellegrinelli, A., Pruneri, G., Miceli, R., Testi, A., Pennisi, M., Di Chio, M. C., Matteucci, P., Carniti, C., Facchetti, F., Rossi, G. & Corradini, P., Apr 1 2019, In : Leukemia. 33, 4, p. 1047-1051 5 p.

Research output: Contribution to journalLetter

Open Access
1 Citation (Scopus)
Sarcoma
Recurrence
Survival
Neoplasms
Incidence

Is a pharmacogenomic panel useful to estimate the risk of oxaliplatin-related neurotoxicity in colorectal cancer patients?

Nichetti, F., Falvella, F. S., Miceli, R., Cheli, S., Gaetano, R., Fucà, G., Infante, G., Martinetti, A., Antoniotti, C., Falcone, A., Di Bartolomeo, M., Cremolini, C., de Braud, F. & Pietrantonio, F., Oct 1 2019, In : Pharmacogenomics Journal. 19, 5, p. 465-472 8 p.

Research output: Contribution to journalArticle

oxaliplatin
Pharmacogenetics
Colorectal Neoplasms
Single Nucleotide Polymorphism

Long-term outcome of re-irradiation for recurrent or second primary head and neck cancer: A multi-institutional study of AIRO—Head and Neck working group

Orlandi, E., Bonomo, P., Ferella, L., D'Angelo, E., Maddalo, M., Alterio, D., Infante, G., Bacigalupo, A., Argenone, A., Iacovelli, N. A., Desideri, I., Meduri, B., Triggiani, L., Volpe, S., Belgioia, L., Dionisi, F., Romanello, D. A., Fallai, C. & Miceli, R., Oct 1 2019, In : Head and Neck. 41, 10, p. 3684-3692 9 p.

Research output: Contribution to journalArticle

Second Primary Neoplasms
Head and Neck Neoplasms
Neck
Survival
Kaplan-Meier Estimate
1 Citation (Scopus)

Maintenance Therapy with Panitumumab Alone vs Panitumumab Plus Fluorouracil-Leucovorin in Patients with RAS Wild-Type Metastatic Colorectal Cancer: A Phase 2 Randomized Clinical Trial

Pietrantonio, F., Morano, F., Corallo, S., Miceli, R., Lonardi, S., Raimondi, A., Cremolini, C., Rimassa, L., Bergamo, F., Sartore-Bianchi, A., Tampellini, M., Racca, P., Clavarezza, M., Berenato, R., Caporale, M., Antista, M., Niger, M., Smiroldo, V., Murialdo, R., Zaniboni, A. & 10 others, Adamo, V., Tomasello, G., Giordano, M., Petrelli, F., Longarini, R., Cinieri, S., Falcone, A., Zagonel, V., Di Bartolomeo, M. & De Braud, F., Jan 1 2019, In : JAMA oncology.

Research output: Contribution to journalArticle

Leucovorin
Fluorouracil
Colorectal Neoplasms
Randomized Controlled Trials
Therapeutics